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Abstract. 
 
Nitric oxide is a chemical messenger impli-
cated in neuronal damage associated with ischemia, 
neurodegenerative disease, and excitotoxicity. Excito-
toxic injury leads to increased NO formation, as well as 
stimulation of the p38 mitogen-activated protein 
(MAP) kinase in neurons. In the present study, we de-
termined if NO-induced cell death in neurons was de-
pendent on p38 MAP kinase activity. Sodium nitroprus-
side (SNP), an NO donor, elevated caspase activity and 
induced death in human SH-SY5Y neuroblastoma cells 
and primary cultures of cortical neurons. Concomitant 
treatment with SB203580, a p38 MAP kinase inhibitor, 
diminished caspase induction and protected SH-SY5Y 
cells and primary cultures of cortical neurons from
NO-induced cell death, whereas the caspase inhibitor 
zVAD-fmk did not provide signiﬁcant protection. A 
role for p38 MAP kinase was further substantiated by 
the observation that SB203580 blocked translocation of 
the cell death activator, Bax, from the cytosol to the mi-
tochondria after treatment with SNP. Moreover, ex-
pressing a constitutively active form of MKK3, a direct 
activator of p38 MAP kinase promoted Bax transloca-
tion and cell death in the absence of SNP. Bax-deﬁcient 
cortical neurons were resistant to SNP, further demon-
strating the necessity of Bax in this mode of cell death. 
These results demonstrate that p38 MAP kinase activ-
ity plays a critical role in NO-mediated cell death in 
neurons by stimulating Bax translocation to the mito-
chondria, thereby activating the cell death pathway.
Key words: caspase • excitotoxicity • neuronal cell 
death • p53 • mitochondria
 
Introduction
 
Nitric oxide has been implicated as a critical mediator of
neuronal injury in association with both acute and chronic
neurological insults (Beal, 1996; Dawson and Dawson,
1996; Heales et al., 1999). Pharmacological inhibitors of
neuronal nitric oxide synthase (nNOS)
 
1
 
 have been shown
to significantly reduce lesions produced in response to fo-
cal ischemia (Yoshida et al., 1994), administration of the
neurotoxin MPTP (Schulz et al., 1995a), and intrastriatal
injections of NMDA (Schulz et al., 1995b). Moreover,
mice that are deficient in the nNOS gene exhibit signifi-
cant protection against cerebral ischemia (Huang et al.,
1994) and NMDA-mediated excitotoxicity (Dawson et al.,
1996; Ayata et al., 1997).
The neuroprotection conferred by the absence of nNOS
expression may relate to a reduction in oxygen free radi-
cals and related nitric oxide reaction products. For exam-
ple, nitric oxide can react with superoxide to produce per-
oxynitrite and other oxygen radicals (Beckman et al.,
1990). These reactive agents, in turn, can produce exten-
sive cellular damage by oxidizing DNA, protein, and lipids
(Beckman and Crow, 1993). Noted examples of dam-
age include nitrosylation of proteins and oxidative DNA
damage with accumulation of strand breaks (Inoue and
Kawanishi, 1995). Damage to these cellular substrates is
presumed to activate additional downstream signaling
pathways, which culminate in apoptosis. However, such
signaling pathways that are activated in neurons in re-
sponse to nitric oxide production have not been identi-
fied.
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Abbreviations used in this paper:
 
 ERK, extracellular signal–regulated
kinase; GFP, green fluorescent protein; JNK, c-Jun NH
 
2
 
-terminal kinase;
MAP kinase, mitogen-activated protein kinase; MEK, MAP kinase ki-
nase; SNP, sodium nitroprusside; nNOS, neuronal nitric oxide synthase. 
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The mitogen-activated protein (MAP) kinases com-
prise a family of serine/threonine kinases that function as
critical mediators of signal transduction (Cohen, 1997; Ip
and Davis, 1998). Members of the MAP kinase super-
family include the extracellular signal–regulated kinases
(ERKs), the Jun NH
 
2
 
-terminal kinase (JNK), and the p38
MAP kinases. ERKs (ERK1 and ERK2) are activated in
response to mitogen or growth factor stimulation (Boul-
ton et al., 1991; Qui and Green, 1992; Loeb et al., 1992;
Cobb, 1999). In contrast, the JNK and p38 MAP kinases
are activated by a variety of cellular stresses including ul-
traviolet light, hyperosmolarity, heat shock, and proin-
flammatory cytokines (D’erijard et al., 1995; Galcheva-
Gargova et al., 1994; Han et al., 1994; Kyriakis et al., 1994;
Rouse et al., 1994). p38 MAP kinase and JNK recently
have been shown to be involved in NGF deprivation-
induced cell death in a neuronal cell line (Xia et al., 1995;
Kummer et al., 1997). In addition, p38 MAP kinase and
JNK activity have also been implicated in developmental
neuronal cell death (Aloyz et al., 1998; Maroney et al.,
1998), as well as cell death associated with axotomy
(Glicksman et al., 1998) and excitotoxicity (Kawasaki et
al., 1997; Yang et al., 1997).
Nitric oxide production in neurons, as well as in other
cell types, may activate caspaselike proteases (Tamatani
et al., 1998; Jun et al., 1999). Caspases comprise a family of
cysteine proteases that are implicated as cell death effec-
tors in both vertebrate and invertebrate cells (Nicholson
and Thornberry, 1997; Porter et al., 1997; Cryns and Yuan,
1998). The release of cytochrome 
 
c
 
 and other apoptogenic
factors from injured mitochondria recently have been
shown to activate caspases (Kluck et al., 1997; J. Yang et al.,
1997). Mitochondrial integrity appears to be regulated, in
part, by members of the Bcl-2 family (Reed, 1997). In re-
sponse to apoptotic signals, Bax, a proapoptotic member
of this family, is redistributed from the cytosol to the mito-
chondria (Hsu et al., 1997; Wolter et al., 1997), where it
precipitates a decline in mitochondrial membrane poten-
tial followed by cytochrome 
 
c
 
 release and caspase activa-
tion (J.G. Xiang et al., 1996; Vekrellis et al., 1997; Eskes
et al., 1998; Marzo et al., 1998; Narita et al., 1998; Shimizu
et al., 1999).
Since several neuronal cell types contain caspase pro-
teins that are activated by the same stimuli shown to up-
regulate p38 MAP kinase activity (Xia et al., 1995; Ka-
wasaki et al., 1997), it is conceivable that the p38 MAP
kinase contributes to the activation of caspases. Therefore,
we evaluated the relationship between p38 MAP kinase
activity, Bax translocation, and caspase activation. We re-
port here that treatment with a nitric oxide donor, sodium
nitroprusside (SNP), stimulated Bax translocation to the
mitochondria, which was followed by caspase activation.
Administration of p38 MAP kinase inhibitors blocked
Bax translocation, partially suppressed caspase activation,
and significantly enhanced neuronal survival. In contrast,
caspase inhibitors completely suppressed SNP-mediated
caspase induction, but failed to confer the same degree of
protection from cell death as the p38 MAP kinase inhibi-
tors. These findings suggest that nitric oxide–mediated cell
death in neurons may occur through a p38 MAP kinase–
and Bax-dependent pathway, but in a caspase-indepen-
dent manner. Moreover, the present results suggest that
 
p38 MAP kinase promotes apoptosis by facilitating Bax
translocation to the mitochondria.
 
Materials and Methods
 
Materials
 
Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD-fmk),
z-Asp-Glu-Val-Asp-fmk (zDEVD-fmk), and the fluorogenic caspase sub-
strate zDEVD-AFC were purchased from Enzyme Systems Product. SNP
was obtained from ICN Biomedicals. The MAP kinase kinase (MEK) in-
hibitor, U0126, was obtained from Promega, and the p38 MAP kinase in-
hibitor, SB203580, and its structurally related negative control compound,
SB202474 (Lee et al., 1994), were obtained from Calbiochem. Propidium
iodide and Hoechst 33342 were obtained from the Sigma Chemical Co. A
cell lysis buffer for fluorogenic caspase activity assays was obtained from
CLONTECH Laboratories, Inc. (ApoAlert CPP32 assay kit).
 
Cell Culture
 
SH-SY5Y human neuroblastoma cells were obtained from the American
Type Tissue Culture Collection and were routinely maintained in DME/
Ham’s F12 medium with 10% FBS, 100 U/ml penicillin, and 100 
 
m
 
g/ml
streptomycin. SH-SY5Y cells were plated at 5.0 
 
3 
 
10
 
4
 
 cells/35-mm dish for
determination of cell number or at 10
 
6
 
 cells/60-mm dish for Western blot
analysis and caspase activity measurements. SH-SY5Y cells were rou-
tinely plated 1–2 d before treatment (considered day 0). For determina-
tion of viable cell number, triplicate cultures of SH-SY5Y cells were
trypsinized, collected by centrifugation (2,000 rpm, 8 min), resuspended in
Hanks’ balanced salt solution containing trypan blue, and counted using a
hemacytometer.
Bax-deficient mice were generated from a 129/Sv 
 
3
 
 
 
C3H background
(Knudson et al., 1995), and p53-deficient mice were generated from a 129/
Sv 
 
3 
 
C57BL/6 background (Donehower et al., 1992) as described previ-
ously. The genotypes of the mating pairs and all offspring were deter-
mined by PCR, using DNA extracted from the tail (Timme and Thomp-
son, 1994). Cortical neurons from individual animals were separately
cultured, and their genotypes were determined before treatment.
Neuronal cultures derived from postnatal day 0 (P0) cortex were estab-
lished as previously described (H. Xiang et al., 1996; Xiang et al., 1998). In
brief, newborn mice were killed by decapitation, and the cortex was dis-
sected free in Hanks’ balanced salt solution. The dissected tissues were
treated with trypsin for 25 min, washed, and dissociated by trituration.
The cells were plated on a poly-
 
D
 
-lysine–coated substrate in Neurobasal
medium plus B27 supplements (GIBCO BRL; Brewer, 1997) at 1.25 
 
3 
 
10
 
5
 
cells per 15-mm well for neuronal counting, or at 1.5–2 
 
3 
 
10
 
6
 
 cells/60-mm
dish for caspase activity assays. The cultures were maintained at 37
 
8
 
C in a
5% CO
 
2 
 
atmosphere. Cultures, maintained under these conditions, were
previously shown to contain 
 
z
 
95% neurons, as determined by cell mor-
phology and immunocytochemistry for neurofilament and GFAP (H.
Xiang et al., 1996).
 
Assessment of Neuronal Viability
 
Neurons were routinely maintained in culture for 4 d before treatment.
The number of viable neurons was determined by counting cells within
four premarked reticules (1 mm
 
2
 
/well) at the time of treatment and at var-
ious times after treatment. Viable neurons were identified according to
the following criteria: that neurites were uniform in diameter, smooth in
appearance, and at least twice as long as the soma; that somata were nor-
mally smooth and round to oval in shape; and that nuclei were normal in
appearance, without evidence of condensation or fragmentation. In con-
trast, degenerating, nonviable neurons possessed neurites that were frag-
mented and beaded, and the somata were rough, shrunken, vacuolated,
and irregular in shape. The nuclei of nonviable neurons were often con-
densed or fragmented.
 
Fluorogenic Caspase Assays
 
Caspase activity was determined by monitoring the cleavage of a spe-
cific fluorogenic caspase substrate, zDEVD-AFC (z-Asp-Glu-Val-Asp-
7-amino-4-trifluoromethyl coumarin). The cells were plated and main-
tained as described above. At specific times after treatment, cells were
collected by scraping in cold PBS, centrifuged (2,000 rpm, 8 min), and 
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lysed on ice for 10 min in the cell lysis buffer provided in the CLONTECH
ApoAlert™ CPP32 assay kit. The extracts were kept at 
 
2
 
20
 
8
 
C until the
time of assay. At that time, the extracts were thawed and reacted with the
fluorogenic caspase substrate (zDEVD-AFC, 100 
 
m
 
M) in reaction buffer
(0.1 M Hepes buffer, 0.1% Chaps, 1% sucrose, pH 7.4) containing 1 mM
DTT. The mixtures were maintained at 37
 
8
 
C for 40 min and subsequently
analyzed in a fluorometer (Perkin Elmer) equipped with a 400-nm excita-
tion filter and a 505-nm emission filter. The levels of relative fluorescence
were normalized against the protein concentration of each extract, which
was determined using the Bio-Rad protein assay reagent. Rabbit IgG was
used as a protein standard.
 
p38 and JNK Western Blot Analysis
 
SH-SY5Y cells were plated as described above and treated with SNP
(500 
 
m
 
M) or UV irradiation (80 J/m
 
2
 
). Control cultures were sham-treated
to exclude the contribution of disturbing the cultures in association with
the treatment. At the appropriate time points, the cells were lysed in an
extraction buffer as previously described (Xia et al., 1995). Proteins were
resolved by SDS-PAGE on 10% gels, and immunoblotting was performed
as previously described (Hetman et al., 1999) using a phospho-p38 MAPK
(Tyr182) antibody (New England Biolab No. 9211, 1:1,000) and phospho-
JNK (Thr183/Tyr185) antibody (Promega No. V7931, 1:5,000) according
to the manufacturer’s instruction.
 
Fluorescence-activated Cell Sorting
 
Human SH-SY5Y cells were plated at 2.0 
 
3 
 
10
 
6
 
 cells per 60-mm dish. 1 d
after plating, the cells were treated with SNP (500 
 
m
 
M) alone or SNP plus
the p38 MAP kinase inhibitor (20 
 
m
 
M, SB203580) or the caspase inhibitor
zVAD-fmk (20 
 
m
 
M). At 24 and 72 h after treatment, the cells were har-
vested by trypsinization. The trypsin action was stopped by adding serum-
containing medium. Cells were centrifuged (1,400 rpm, 8 min), and resus-
pended in PBS to a final concentration of 5 
 
3 
 
10
 
5
 
 cells/ml. Hoechst 33342
(20 
 
m
 
l/ml, 1 mM stock) and propidium iodide (5 
 
m
 
l/ml, 5 mg/ml stock)
were added sequentially to the cell suspension. The cell suspension was in-
cubated in the dark for 30 min at 37
 
8
 
C in a humidified 5% CO
 
2
 
 atmo-
sphere. Cells were analyzed using an Epics Elite ESP cell sorter flow cy-
tometer (Coulter Diagnostics Systems). Approximately 2.0 
 
3 
 
10
 
4
 
 cells
were analyzed per sample. Fluorescence was analyzed and plotted using
the Multiplus software package (Phoenix Flow Systems). This protocol
determines the absolute number of live (Hoechst 33342-positive/propid-
ium iodide–negative) and dead cells (propidium iodide–positive; Hamori
et al., 1980; Poot et al., 1997).
 
Transfection of SH-SY5Y Cells and Primary
Cortical Neurons
 
An expression construct encoding Bax, which was fused to the enhanced
green fluorescent protein (GFP), was created using full-length human
Bax cDNA (a gift of S.J. Korsmeyer, Howard Hughes Medical Institute
and Dana Farber Cancer Research Center, Boston, MA) inserted into the
vector pEGFP-C3 (CLONTECH Laboratories Inc.; Hsu et al., 1997).
Expression constructs encoding constitutively active MKK3, (pRc/
RSV-Flag-MKK3(Glu)) and dominant negative MKK3 (pRc/RSV-Flag-
MKK3(Ala)) have been described (Xia et al., 1995).
SH-SY5Y cells were plated at a density of 5 
 
3 
 
10
 
4
 
 cells per well into
2-well LabTekII chambered coverglass (Nalge Nunc International) and
maintained at 37
 
8
 
C with 5% CO
 
2
 
 for 24 h. SH-SY5Y cells were replen-
ished with fresh DME/Ham’s F12 culture medium for 1 h at 37
 
8
 
C in 5%
CO
 
2
 
 in preparation for transfection. Postnatal cortical neurons were
plated at 2 
 
3 
 
10
 
5
 
 cells per well and maintained for 3 d before transfection.
DNA transfections were performed using a calcium phosphate precipita-
tion method (Xia et al., 1995). The DNA–Ca
 
2
 
PO
 
4
 
 complexes were pre-
pared by mixing 0.75–2.0 
 
m
 
g DNA per 5 
 
3 
 
10
 
4
 
 cells with 2.5 M CaCl
 
2
 
 in
ddH
 
2
 
O (final CaCl
 
2
 
 concentration 250 mM). Cotransfection experiments
involved the addition of equal amounts of GFP-Bax and MKK3 plasmids.
This solution was added dropwise to a solution of 2
 
3
 
 Hepes-buffered sa-
line, pH 7.08, and precipitates were allowed to form for 30–60 min. The
solution containing DNA precipitates was added to the cultures and gen-
tly mixed. After 12 h, the cells were washed three times with PBS, and
fresh medium was added. 2 d after transfection, cells were treated as spec-
ified in the results. Cells were fixed at appropriate time points with 4%
paraformaldehyde and analyzed using confocal microscopy.
 
Confocal Microscopy
 
Fixed cells were stained with 2.5 
 
m
 
g/ml Hoechst 33342 in PBS for 30 min
to demonstrate nuclear morphology. A subset of cells was treated with
MitoTracker red (20 ng/ml; MitoTracker red CMXRos; Molecular Probes
Inc.) to visualize mitochondria as previously described (Wolter et al.,
1997). Images were collected on a confocal microscope (Nikon Diaphot
300 with a 40
 
3
 
 Fluor 0.85 NA objective). The 488-nm line of a krypton/ar-
gon laser was used for fluorescence excitation of GFP, the 568-nm line for
MitoTracker red and the 364-nm line was used for excitation of Hoechst
33342. Images were processed on the Bio-Rad MRC 1024 UV computer
in z-series, with brightest point projections made through NIH Image
1.62f. TIFF files were processed in Adobe Photoshop 5.0 for simultaneous
GFP and Hoechst 33342 visualization.
 
Results
 
p38 MAP Kinase Activity Is Essential for SNP-induced 
Cell Death in Human SH-SY5Y Neuroblastoma Cells 
and Primary Cultures of Cortical Neurons
 
The involvement of p38 MAP kinase activity in nitric ox-
ide–mediated cell death in neurons was evaluated using
both a neuronal cell line and primary cultures of cortical
neurons. The addition of SNP (500 
 
m
 
M), a nitric oxide do-
nor, to SH-SY5Y human neuroblastoma cells resulted in
significant activation of the p38 MAP kinase (Fig. 1, p-
 
p
 
38
MAPK). Activation was detected as early as 3 h after SNP
treatment and remained elevated even 24 h after treat-
ment relative to vehicle treated control cells. In contrast to
the p38 MAP kinase, SNP treatment did not activate JNK
in SH-SY5Y cells (Fig. 1, 
 
p
 
-JNK). However, both 
 
p
 
38
MAP kinase and JNK were rapidly and profoundly acti-
vated in SH-SY5Y cells in response to UV irradiation, sug-
gesting that JNK can be activated in SH-SY5Y cells in re-
sponse to the appropriate cellular stress. These results
demonstrate that nitric oxide selectively activates the
stress-activated p38 MAP kinase in human SH-SY5Y neu-
roblastoma cells.
The significance of p38 MAP kinase activation was eval-
uated in SNP-induced cell death by using specific inhibi-
tors for MAP kinases. Under control conditions SH-SY5Y
human neuroblastoma cells steadily proliferated, exhibit-
Figure 1. The nitric oxide donor, SNP, activates p38 MAP kinase
but not JNK in SH-SY5Y cells. SH-SY5Y cells were treated with
500 mM SNP, and protein extracts were prepared in duplicate
(except for the 3- and 6-h time points for control) at the indicated
time points to assess the activation of p38 MAP kinase (p-p38
MAPK, top) and JNK (p-JNK, bottom) by Western blotting
using antibodies specific for a phosphorylated (activated) form
of the kinases. Protein extracts from UV-irradiated (80 J/m2)
SH-SY5Y cells were also analyzed in parallel as a positive con-
trol for activation of both p38 MAP kinase and JNK. Arrow-
heads indicate the position of specific immunoreactive bands cor-
responding to distinct phosphorylated p38 MAP kinase and JNK
isoforms. 
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ing a doubling time of 
 
z
 
50 h. SNP (500 
 
m
 
M) induced a
significant degree of cell loss in SH-SY5Y cells in a time-
(Fig. 2) and dose-dependent manner (data not shown).
However, the number of SH-SY5Y cells per dish was
significantly increased when SNP was added together with
the p38 MAP kinase inhibitor, SB203580 (20 
 
m
 
M). In
contrast, only a modest increase in cell number resulted
from the addition of the cell-permeable, irreversible pan-
caspase inhibitor, zVAD-fmk (20 
 
m
 
M).
 
Since the SH-SY5Y cells used in this study proliferate, it
was necessary to determine whether SNP actually induced
cell death in SH-SY5Y cells or simply caused cell cycle ar-
rest. Fluorescence-activated cell sorting was used to ana-
lyze cells on the basis of propidium iodide uptake and total
DNA content, the latter based on the staining intensity of
the Hoechst dye. As seen in the control graph (Fig. 3 A),
the majority of cells was contained in cubicle 5, which rep-
resents viable cells. After SNP treatment (72 h; Fig. 3 B)
there was a significant shift in fluorescence up to cubicle 7,
reflecting the increase in propidium iodide uptake that oc-
curs with membrane damage. The fluorescence intensity
was also shifted to the left on the x-axis, reflecting DNA
degradation. The DNA content profile (Fig. 3 B, inset) re-
vealed no sign of cell accumulation in the G1 or G2 phase
of the cell cycle, but rather demonstrated a significant shift
from a 2N diploid content to a sub-G1 content, which is
consistent with DNA degradation, confirming that the
SNP effect on cell number was due to the induction of cell
death. Addition of the p38 MAP kinase inhibitor (20 
 
m
 
M;
Fig. 3 C) significantly shifted the fluorescent signal back to
cubicle 5, demonstrating that p38 MAP kinase inhibition
maintained cell viability. The size of the sub-G1 peak was
also significantly reduced. In contrast, the addition of
zVAD-fmk (20
 
 
 
m
 
M, Fig. 3 D) only produced a small shift
back to cubicle 5 and failed to reduce the peak associated
with the sub-G1 DNA content, corroborating that the
caspase inhibitor conferred a small degree of protection
from SNP-mediated cell death (Fig. 3 D).
SNP also induced a significant degree of cell loss in pri-
mary cultures of cortical neurons. Neuronal survival was
reduced by 
 
.
 
50% after 48 h of exposure to SNP (Fig. 4).
Concomitant addition of the p38 MAP kinase inhibitor
protected primary cortical neurons from SNP-mediated
cell death. This was not a transient effect, as survival was
maintained in the presence of SB203580 for at least 5 d
(data not shown). To demonstrate that SNP-mediated cell
Figure 2. p38 MAP kinase activity is essential for SNP-induced
cell death in human SH-SY5Y neuroblastoma cells. SH-SY5Y
cells were plated as described in Materials and Methods. After
12–18 h in culture, the cells were treated with DMSO (control) or
SNP (500 mM) in the presence or absence of a p38 MAP kinase in-
hibitor (SB203580, 20 mM) or a cell-permeable, irreversible tri-
peptide caspase antagonist (zVAD-fmk, 20 mM). Cells were
trypsinized and counted on day 1 and day 3 using a hemocytome-
ter. Values represent the mean number of cells per culture 6 SD
of triplicate cultures and are representative of four separate ex-
periments. The number of cells in SNP-treated cultures differed
significantly from all other conditions (P , 0.01, ANOVA).
Figure 3. Fluorescence-activated cell sorting
analysis revealed cell death, but not cell cycle ar-
rest, in SH-SY5Y human neuroblastoma cells in
response to SNP. SH-SY5Y human neuroblas-
toma cells were plated and maintained in basal
culture conditions as described in Materials and
Methods. After 12–18 h in culture, the cells were
treated with (A) DMSO (vehicle control), (B)
SNP (500 mM), (C) SNP plus the p38 MAP ki-
nase inhibitor SB203580 (20 mM), or (D) SNP
plus the caspase antagonist zVAD-fmk (20
mM). 3 d after treatment, fluorescence-activated
cell sorting was performed. Viable cells are con-
tained in cubicle 5. Nonviable cells are repre-
sented in cubicle 7. Everything to the left of cubi-
cles 5–7 represents cellular debris. The insets
represent cellular DNA content profiles as mea-
sured with the DNA binding dye Hoechst 33342.
Positions corresponding to the normal diploid
DNA content (2N) in the G1 phase, a 4N con-
tent in the G2 phase, and a sub-G1 content
(,2N), which are indicative of apoptosis and its
associated DNA fragmentation, are shown. 
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death was specifically associated with activation of the p38
MAP kinase signal transduction pathway, we also evalu-
ated an inhibitor of the ERK pathway. ERKs are activated
by MAP kinase kinase or MEKs in response to growth and
differentiating factors (Boulton et al., 1991; Loeb et al.,
1992; Qui et al., 1992; Cobb, 1999), in contrast to p38 and
JNK, which are activated by cellular stress (Derijard et al.,
1994; Galcheva-Gargova et al., 1994; Han et al., 1994; Kyr-
iakis et al., 1994; Rouse et al., 1994; Xia et al., 1995; Kum-
mer et al., 1997). Inclusion of U0126 (20 
 
m
 
M), a selective
MEK inhibitor (Favata et al., 1998), actually enhanced
neuronal cell death in the presence of SNP (Fig. 4). This is
consistent with the demonstration that the ERK pathway
mediates neuronal survival in response to trophic factor
stimulation (Xia et al., 1995; Hetman et al., 1999). A bio-
logically inactive control compound SB202474 (Inh Con-
trol), which is structurally related to both SB203580 and
U0126 (Lee et al., 1994), had no influence on neuronal sur-
vival, suggesting that the effects observed with SB203580
and U0126 were specifically related to inhibitory actions in
their respective pathways.
The inclusion of zVAD-fmk, a broad spectrum caspase
inhibitor, had no effect on the survival of primary cortical
neurons in culture, in contrast to the modestly protective
results obtained with SH-SY5Y cells. The difference be-
tween SH-SY5Y cells and primary cortical neurons in rela-
tion to the protective effects of zVAD may relate to the
embryonic nature of the SH-SY5Y cells (Johnson et al.,
1999). These results demonstrate that increased levels of
nitric oxide induce cell death in cultured SH-SY5Y cells
and primary cultures of cortical neurons by a mechanism
involving p38 MAP kinase activation.
 
Nitric oxide–inducible Caspase Activity Is Dependent 
on p38 MAP Kinase Activity
 
To further characterize the mechanism by which p38 MAP
kinase promotes neuronal cell death, we determined if p38
MAP kinase activation leads to mitochondrial dysfunc-
tion. To this end, we evaluated the contribution of p38
MAP kinase to caspase induction, which is known to de-
pend on the release of apoptogenic factors from
 
 
 
damaged
mitochondria (Kluck et al., 1997; J. Yang et al., 1997). Hu-
man SH-SY5Y neuroblastoma cells were exposed to SNP
(500
 
 
 
m
 
M), and cellular extracts were evaluated for the
presence of caspase activity by monitoring the cleavage of
the fluorogenic caspase substrate, zDEVD-AFC. Under
control conditions (DMSO treatment), basal levels of
caspase activity were readily detected. Caspase activity
was increased more than sixfold 72 h after exposure to
SNP (Fig. 5). Caspase activation was first detected 24 h af-
ter treatment and was completely inhibited by the cell-per-
meable, irreversible caspase inhibitor, zVAD-fmk (20 
 
m
 
M;
Fig. 5). Maximum inhibition of DEVD cleavage activity
was obtained at concentrations
 
 $
 
10
 
 m
 
M zVAD-fmk (data
not shown). More importantly, caspase activity was also
suppressed by concomitant treatment with the p38 MAP
kinase inhibitor, SB203580. The p38 MAP kinase inhibitor
suppressed caspase activity almost as effectively as zVAD-
fmk at 24 h, and reduced caspase activity by almost 80%
72 h after SNP treatment. The results of this study demon-
strate that p38 MAP kinase activity is involved in the regu-
lation of caspase induction in SH-SY5Y cells in response
to nitric oxide–induced damage, suggesting that p38 MAP
Figure 4. p38 MAP kinase
activity is essential for SNP-
induced cell death in cul-
tured postnatal murine cor-
tical neurons. Postnatal
cortical neurons were plated
and maintained in basal cul-
ture conditions for 4 d as
described in Materials and
Methods. Cells were treated
with DMSO (vehicle control)
or with a single dose of SNP
(500 mM) in the presence or
absence of the p38 MAP ki-
nase inhibitor SB203580 (p38
Inh, 20 mM), the MEK inhib-
itor U0126 (MEK Inh, 20
mM), the structurally related negative control compound
SB202474 (Inh Control, 20 mM), or the broad spectrum caspase
inhibitor zVAD-fmk (zVAD, 20 mM). Neuronal survival was as-
sessed 48 h later by counting the number of viable neurons (H.
Xiang et al., 1996). All data are the means 6 SD of 12 cultures
from three separate experiments. Neuronal survival in cultures
treated with SNP differed significantly from survival in non-
treated cultures or cultures treated with SNP plus the p38 MAP
kinase inhibitor (P , 0.001, ANOVA). Neuronal survival in cul-
tures treated with SNP plus the MEK inhibitor differed signifi-
cantly from survival in all other conditions (P , 0.001, ANOVA).
Figure 5. SNP-mediated in-
duction of caspase activity in
SH-SY5Y cells requires p38
MAP kinase activity. SH-
SY5Y cells were plated in 60-
mm dishes as described in
Materials and Methods. Af-
ter 24 h in culture, the cells
were treated with DMSO
(Control) or SNP (500 mM)
in the presence or absence of
a cell-permeable inhibitor of
p38 MAP kinase 203580 (p38
Inhib, 20 mM), or an irrevers-
ible tripeptide caspase antag-
onist zVAD-fmk (20 mM).
The cells were harvested at 24 or 72 h, and cytosolic extracts were
prepared and evaluated for zDEVD-AFC cleavage activity as de-
scribed in Materials and Methods. The extracts were incubated
with a fluorogenic substrate, zDEVD-AFC (100 mM final con-
centration; Enzyme Systems Products) at 378C. The extent of
substrate hydrolysis was determined after a 45-min incubation
period (hydrolysis is linear for up to 60 min), and is expressed as
arbitrary fluorescence units per milligram of protein. The results
represent the mean 6 SD (n 5 3 cultures/condition) and are rep-
resentative of five separate experiments. Caspase activity in SNP-
treated cultures differed significantly from control cultures and
cultures treated with SNP plus the p38 MAP kinase inhibitor or
zVAD-fmk (P , 0.001, ANOVA). Some bars do not express
standard error bars because they are small enough to be con-
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kinase activation is linked to a loss of mitochondrial in-
tegrity.
Nitric Oxide–induced Cell Death Involves Alterations 
in the Intracellular Distribution of the Cell Death 
Activator, Bax
The demonstration that p38 MAP kinase activity was nec-
essary for caspase activation suggested that p38 MAP ki-
nase may regulate some aspect of mitochondrial function,
since the release of cytochrome c from damaged mito-
chondria represents an important pathway for activating
caspases (Liu et al., 1996; Zou et al., 1997). Overexpress-
ing the Bcl-2 family member, Bax, is sufficient to precipi-
tate a decline in mitochondrial membrane potential, in-
creased free radical production, and caspase activation
(J.G. Xiang et al., 1996). These Bax-mediated alterations
in mitochondrial function are consistent with the recent
demonstration that cell injury promotes Bax translocation
from the cytosol to the mitochondria (Hsu et al., 1997;
Wolter et al., 1997; Goping et al., 1998).
Therefore, we determined if nitric oxide initiated neu-
ronal damage by stimulating Bax translocation to the mi-
tochondria. The intracellular distribution of the Bax pro-
tein was evaluated by transfecting SH-SY5Y cells or
primary cortical neurons with a GFP-Bax fusion construct
(Hsu et al., 1997; Wolter et al., 1997). DMSO-treated con-
trol cells typically displayed a diffuse, cytosolic pattern of
fluorescence (Fig. 6, A and H), which was still maintained
up to 8 h after SNP treatment (Fig. 6 B). However, SNP
treatment (500 mM) produced significant changes in the
distribution of fluorescence that was first detected 12 h af-
ter treatment and involved a change from a diffuse, cyto-
solic distribution to a punctate pattern of fluorescence
(Fig. 6 C). This change was shown to represent the redis-
tribution of Bax from the cytosol to the mitochondria, as
demonstrated by the nearly complete overlap between
GFP-Bax fluorescence and the location of mitochondria
(Fig. 7), as revealed by staining with MitoTracker red
(Wolter et al., 1997). These results are consistent with pre-
vious data on Bax translocation demonstrated for many
different cell types, including neurons, in response to dis-
tinct forms of cell death stimuli (Hsu et al., 1997; Wolter
et al., 1997; Youle, R.J., unpublished observations). After
24 h of exposure to SNP, .70% of SH-SY5Y cells and pri-
mary cortical neurons displayed this punctate pattern of
fluorescence (Fig. 6, D and I). This punctate pattern was
not observed in SNP-treated cells that were transfected
with GFP alone, in contrast to GFP-Bax, demonstrating
that changes in the fluorescence pattern were specifically
due to the Bax protein (data not shown).
Bax translocation was generally observed in cells that
exhibited retraction or fragmentation of cellular processes
and shrinkage of the cell body. In contrast, at 12 h, it was
possible to identify cells that displayed a punctate pattern
of GFP-Bax fluorescence in combination with a healthy
nucleus, suggesting that Bax translocation precedes nu-
clear fragmentation (Fig. 6 C). We did not observe cells
displaying nuclear changes in the absence of Bax translo-
cation, suggesting that changes in the distribution of the
Bax protein precede both caspase activation and alter-
ations in nuclear morphology. To ensure that Bax translo-
cation did not simply result from a change in cell shape,
cell shrinkage was produced by exposing SH-SY5Y cells to
a dilute solution of trypsin (0.125%, 1 min). Although this
caused SH-SY5Y cells to retract their processes and round
up, thereby reducing their size, the GFP-Bax signal was
still diffusely distributed throughout the cytoplasm (data
not shown). In marked contrast to SNP treatment alone,
the concomitant addition of the p38 MAP kinase inhibitor,
SB203580, suppressed Bax translocation in both SH-SY5Y
cells and primary cortical neurons, maintaining a diffuse
cytoplasmic distribution of fluorescence (Fig. 6, F and J).
The addition of U0126, a MEK inhibitor, which actually
enhanced neuronal cell death in the presence of SNP (Fig.
4), failed to prevent the intracellular redistribution of Bax
(data not shown). Similarly, the cell-permeable caspase in-
hibitor, zVAD-fmk (20 mM), also had no effect on Bax
translocation induced by SNP exposure (Fig. 6 G). These
results suggest that p38 MAP kinase activity regulates the
translocation of Bax from the cytosol to the mitochondria
in response to nitric oxide–induced damage in neurons.
Bax translocation was observed in cells that displayed
varying degrees of chromatin condensation and nuclear frag-
mentation as depicted by the DNA binding dye, Hoechst
33342. The reduction in the number of cells expressing a
healthy, diffuse pattern of chromatin staining was consis-
tent with the loss of viability measured by direct cell
counting and FACS analysis as described in Figs. 1 and 2.
Approximately 63% of DMSO-treated GFP-Bax–trans-
fected control SH-SY5Y cells displayed intact nuclei with-
out any evidence of chromatin condensation or nuclear
fragmentation (percentage of cells with intact nuclei 6
SD; 63.25 6 5.1, n 5 4). The reduction in viable, trans-
fected control cells relative to nontransfected cells is at-
tributed to plasma membrane damage resulting from the
transfection process. 24 h after SNP treatment (500 mM),
only 32% of transfected cells were viable based on nuclear
morphology (percentage of cells with intact nuclei 6 SD;
32.70 6 2.89, n 5 5). Treatment with the p38 MAP kinase
inhibitor (SB203580, 20 mM; percentage of cells with intact
nuclei 6 SD; 55.67 6 4.04, n 5 4) or the broad spectrum
caspase inhibitor, zVAD-fmk (20 mM; percentage of cells
with intact nuclei 6 SD; 50.50 6 2.12, n 5 3) significantly
reduced chromatin condensation and nuclear fragmenta-
tion at 24 h. Interestingly, although zVAD-fmk prevented
changes in nuclear morphology, these cells still displayed
Bax translocation as depicted by a punctate pattern of
GFP fluorescence (Fig. 6 G). The results of this study
demonstrate that p38 MAP kinase promotes cell death in
response to injury by stimulating Bax translocation to the
mitochondria.
The relationship between p38 MAP kinase activity and
Bax translocation was directly evaluated by transfecting
SH-SY5Y cells with a constitutively active form of the
MAP kinase kinase, MKK3. MKK3 specifically phosphor-
ylates and activates p38 MAP kinase (D’erijard et al.,
1995; Davis, 1998). In the absence of any treatment, 25%
of GFP-Bax–transfected SH-SY5Y cells exhibited evi-
dence of Bax translocation (Fig. 8), with the rest of the
cells displaying a diffuse cytoplasmic distribution as de-
scribed for Fig. 6. In contrast, 75% of GFP-Bax–trans-
fected cells displayed evidence of Bax translocation when
cotransfected with a plasmid expressing constitutively ac-Ghatan et al. p38 MAP Kinase in Neuronal Cell Death 341
tive MKK3 (Fig 8). These same cells also exhibited nuclear
condensation or fragmentation consistent with the induc-
tion of apoptosis (data not shown). However, the p38
MAP kinase inhibitor, SB203580, suppressed Bax translo-
cation induced by activated MKK3 to the level of control
cells in the presence (Fig. 8) or absence of SNP (data
not shown). Furthermore, expressing constitutively active
MKK3 in the presence of a suboptimal dose of SNP
Figure 6. SNP induces p38 MAP kinase–dependent alterations in the intracellular distribution of the cell death activator, Bax. SH-
SY5Y cells (A–G) and cortical neurons (H–J) were plated in 2-well LabTek II chambered coverglass as described in Materials and
Methods. After 24 h (SH-SY5Y cells) or 72 h (primary neurons) in culture, the cells were transfected with the GFP-Bax fusion construct
using a calcium phosphate precipitation method as described in Materials and Methods. 2 d after transfection, the cells were treated
with DMSO (Control; A and H), SNP (500 mM; B–D, F, G, I, and J), or staurosporine (0.5 mM; E). A subset of cells treated with SNP
were also concomitantly treated with the p38 MAP kinase inhibitor, SB203580 (20 mM; F and J), or the cell-permeable caspase inhibi-
tor, zVAD-fmk (20 mM; G). GFP-Bax fluorescence (green) was assessed at 8 (B), 12 (C), or 24 h (A and D–J) by confocal microscopy
as described in Materials and Methods. Nuclear integrity was assessed by staining the cultures with the DNA binding dye Hoechst 33342
(2.5 mg/ml; purple, the blue emission normally associated with this dye was digitally altered to purple to enhance its visualization). Apop-
totic cells exhibited chromatin condensation and nuclear fragmentation. The results are representative of six separate transfection ex-
periments for each condition. Bar: (A–G) 10 mm; (I) 20 mm; (H and J) 40 mm.The Journal of Cell Biology, Volume 150, 2000 342
showed no additive effect on the number of cells display-
ing Bax translocation (Fig. 8). These results suggest that
activating p38 MAP kinase through MKK3 mimics the
pathway stimulated by SNP. As a control for the specific-
ity of the activated MKK3 response, SH-SY5Y cells were
also cotransfected with GFP-Bax and a plasmid encoding
a dominant negative form of MKK3 (Xia et al., 1995).
Cells expressing dominant negative MKK3 did not display
evidence of Bax translocation. In fact, the dominant nega-
tive MKK3 significantly reduced Bax translocation in cells
treated with SNP (Fig. 8). These results demonstrate that
p38 MAP kinase activity is sufficient to stimulate Bax
translocation to the mitochondria even in the absence of
injury and is necessary for SNP-induced Bax translocation.
Moreover, these studies suggest that Bax plays an essential
role in nitric oxide–mediated cell death in neurons.
Bax Is Required for Nitric Oxide–mediated Cell Death
To determine if Bax was essential for SNP-induced cell
death, we evaluated SNP-mediated neurotoxicity in pri-
mary cultures of postnatal cortical neurons lacking a func-
tional Bax gene (Knudson et al., 1995). In Bax wild-type
(Bax 1/1) cortical neurons, SNP exposure produced sig-
nificant cell death in a dose- and time-dependent manner
(Fig. 9, A–D). More than 80% of wild-type cortical neu-
rons were killed 4 d after SNP treatment (Fig. 9 A, 500–
1,000 mM). Morphological evidence of neuronal damage
was clearly observed 24 h after treatment and was associ-
ated with significant loss of viable cell bodies and neurite
fragmentation as seen under phase-contrast optics (data
not shown). In marked contrast, SNP treatment did not
significantly alter the survival of Bax-deficient cortical
neurons compared with nontreated or DMSO-treated
control neurons (Fig. 9 B, 500 mM). Bax-deficient neurons
appeared remarkably healthy 4 d after SNP treatment
(500 mM) and showed little morphological evidence of
damage. Even at concentrations as high as 1,000 mM SNP,
there was a stable population of Bax-deficient neurons
Figure 7. SNP induces Bax translocation to the
mitochondria. SH-SY5Y cells were plated and
transfected with GFP-Bax using Fugene (Roche
Molecular Biochemical) according to the manu-
facturer’s instructions. 1 d after transfection, the
cells were treated with SNP (500 mM). The cells
were also treated for 30 min before observa-
tion with 20 ng/ml MitoTracker red CMXRos to
stain mitochondria. GFP-Bax (green) and Mi-
toTracker (red) fluorescence was assessed at 18 h
after SNP treatment by laser fluorescence confo-
cal microscopy as described in Materials and
Methods. GFP-Bax was diffusely distributed in
control cells as seen in Fig. 6 A. However, 18 h
after SNP treatment, GFP-Bax (A, green) local-
izes primarily to mitochondria (B, red) based on
the overlap of the GFP-Bax and MitoTracker
fluorescent images (C, Merged, yellow). There was no difference in the pattern of mitochondrial distribution between control and SNP-
treated cells as assessed by MitoTracker red fluorescence.
Figure 8. p38 MAP kinase activity is necessary and sufficient to
induce Bax translocation. SH-SY5Y cells were plated in 2-well
Lab-Tek II chambered coverglass as described in Materials and
Methods. After 24 h in culture, the cells were either transfected
with the GFP-Bax fusion construct alone or were cotransfected
with GFP-Bax and a constitutively active or a dominant negative
form of MKK3 using a calcium phosphate precipitation method
as described in Materials and Methods. 2 d after transfection, the
cells were treated with DMSO (Control) or SNP (500 mM). A
subset of cells were also concomitantly treated with the p38 MAP
kinase inhibitor, SB203580 (20 mM). The number of transfected
cells displaying a cytoplasmic, diffuse distribution or a punctate
distribution of GFP-Bax fluorescence was assessed at 24 h by
confocal microscopy as described in Materials and Methods, and
used to determine the percentage of cells displaying Bax translo-
cation (punctate distribution). The results are the average of six
separate transfection experiments for each condition using qua-
druplicate wells for each experiment. Between 500 and 1,000
GFP-Bax–transfected cells were counted for each condition. The
number of cells displaying GFP-Bax translocation in cultures
treated with SNP differed significantly from that in cultures
treated with DMSO or SNP plus the p38 MAP kinase inhibitor,
SB203580 (20 mM; P , 0.001, ANOVA). The number of cells dis-
playing Bax translocation in cultures cotransfected with activated
MKK3 differed significantly from GFP-Bax–transfected cells,
GFP-Bax/dominant negative MKK3–cotransfected cells or GFP-
Bax/activated MKK3–cotransfected cells treated with SB203580
(20 mM) (P , 0.001, ANOVA).Ghatan et al. p38 MAP Kinase in Neuronal Cell Death 343
(25%) surviving 4 d after treatment, whereas Bax wild-
type neurons were effectively eliminated after 3 d of SNP
exposure. In contrast to Bax deficiency, there was no pro-
tection conferred against SNP-mediated cytotoxicity by
the absence of the p53 gene (Fig. 9 D). p53-deficient neu-
rons exhibited the same sensitivity towards SNP as p53
wild-type (Fig. 9 C) and Bax wild-type neurons (Fig. 9 A).
These findings are in direct contrast to our previous re-
sults, demonstrating that the absence of either p53 or Bax
was sufficient to protect postnatal cortical neurons from
cell death induced by camptothecin or glutamate (H. Xiang
et al., 1996; Xiang et al., 1998). These results suggest that
nitric oxide can induce neuronal cell death by activating a
Bax-dependent pathway independently of p53.
Discussion
Excessive generation of nitric oxide has been implicated in
neuronal cell death, which is associated with a wide range
of neurological disorders including Parkinson’s disease,
Alzheimer’s disease, amyotrophic lateral sclerosis, multi-
ple sclerosis, and stroke (Heales et al., 1999). Unfortu-
nately, the biochemical mechanisms underlying nitric ox-
ide–mediated toxicity are poorly understood. Excessive
stimulation by the excitatory neurotransmitter, glutamate,
promotes nitric oxide–mediated neurotoxicity via coupling
with the PSD-95 protein (Christopherson et al., 1999; Satt-
ler et al., 1999) and, concomitantly, initiates a stress-acti-
vated protein kinase pathway (Kawasaki et al., 1997).
These results suggest that increased levels of nitric oxide
may be coupled to the activation of downstream transduc-
tion cascades. In the present study, we evaluated the sig-
naling pathways associated with nitric oxide–mediated cell
death in a neuronal cell line and in primary cultures of mu-
rine cortical neurons. The results of this study demonstrate
all of the following: (1) that nitric oxide–induced cell death
in neurons is mediated through p38 MAP kinase activity;
(2) that p38 MAP kinase activity regulates the transloca-
tion of the cell death activator, Bax, from the cytosol to
the mitochondria; (3) that Bax translocation represents an
important step in nitric oxide–mediated cell death, since
the p38 MAP kinase inhibitor blocks Bax translocation to
the mitochondria while conferring protection from cell
death; and (4) that p38 MAP kinase activity facilitates
caspase activation, but promotes neuronal cell death by a
caspase-independent pathway.
p38 MAP Kinase Is Necessary for Nitric Oxide–induced 
Cell Death in Neurons
Our results demonstrate that nitric oxide–induced cell
death of human neuroblastoma cells and murine cortical
neurons in culture is dependent on p38 MAP kinase activ-
ity and the presence of a functional Bax gene. p38 MAP
kinase activity has been associated with the induction of
apoptosis in numerous cell types and in response to a mul-
titude of cellular stresses (Xia et al., 1995; Brenner et al.,
1997; Ichijo et al., 1997; Schwenger et al., 1997). However,
this is not a universal finding as p38 MAP kinase activa-
tion has also been shown to promote cell survival (Nemoto
et al., 1998; Roulston et al., 1998; Assefa et al., 1999), sug-
gesting that the role of the p38 MAP kinase pathway in
apoptosis/survival is both cell type– and stimulus-depen-
dent. Much of the complexity surrounding the actions of
p38 MAP kinase may stem from the presence of distinct
p38 isoforms, which have been shown to play different
roles in apoptosis (Nemoto et al., 1998).
Stress-activated kinases appear to be critical for induc-
tion of apoptosis in neurons. Trophic factor withdrawal
(Xia et al., 1995; Kummer et al., 1997) or administration of
hypoxia (Conrad et al., 1999) to pheochromocytoma cells
(PC12 cells) results in the sustained activation of both p38
MAP kinase and JNK, whereas glutamate administration
provokes a similar activation in cultured cerebellar gran-
Figure 9. Bax is required for nitric oxide–medi-
ated cell death. Postnatal cortical neurons were
plated and maintained in basal culture conditions
for 4 d as described in Materials and Methods.
Neurons were derived from either the Bax strain of
mice (Bax 1/1, A; Bax 2/2, B) or the p53 strain
of mice (p53 1/1, C; p53 2/2, D). Cells were
subsequently treated with varying concentrations
of SNP (0, 200, 500, and 1,000 mM). Neuronal
survival was assessed by counting the number of
viable neurons (H. Xiang et al., 1996). All data
are the means 6 SEM of triplicate cultures, and
are representative of three separate experiments
with similar results. Neuronal survival in Bax
2/2 cultures treated with SNP at 500 and 1,000
mM differed significantly from survival in identi-
cally treated Bax 1/1 cultures (P , 0.001,
ANOVA). Neuronal survival in p53 2/2 cul-
tures treated with SNP did not differ significantly
from survival in identically treated p53 1/1 cul-
tures (P . 0.35, ANOVA). Most data points do
not express standard error bars because they are
small enough to be contained within the symbols.The Journal of Cell Biology, Volume 150, 2000 344
ule neurons (Kawasaki et al., 1997). Increased expression
of ASK-1, JNK, and p38 MAP kinase has also been de-
tected in apoptotic neurons and glia after spinal cord in-
jury in rats (Nakahara et al., 1999). Consistent with these
findings, inhibition of p38 MAP kinase activity suppressed
the death of PC12 cells (Xia et al., 1995; Kummer et al.,
1997; Le Niculescu et al., 1999) and sympathetic ganglion
neurons (Horstmann et al., 1998) after trophic factor with-
drawal, and suppressed glutamate-mediated cell death in
cerebellar granule cells (Kawasaki et al., 1997). The results
from the present study are consistent with reports demon-
strating that p38 signaling mediates neuronal cell death in
response to a cytotoxic stimulus and suggest that increased
levels of nitric oxide may initiate neuronal cell death
through p38 MAP kinase signaling.
p38 MAP Kinase Regulates Bax Translocation and 
Caspase Activation
The downstream signaling events that couple p38 MAP ki-
nase activation with neuronal cell death have not been
previously identified. One intriguing possibility is that in-
jury-induced changes in neuronal viability stem from de-
clining mitochondrial function initiated by alterations in
the activity of proapoptotic members of the Bcl-2 family.
This hypothesis is consistent with the demonstration that
mitochondrial dysfunction, including the loss of mitochon-
drial membrane potential and increased production of re-
active oxygen species, plays an obligate role in excitotoxic
damage (Ankarcrona et al., 1995; Dugan et al., 1995; Rey-
nolds and Hastings, 1995; Schinder et al., 1996), a stimulus
that is also associated with increased production of nitric
oxide (Dawson et al., 1996; Ayata et al., 1997). A relation-
ship between the Bcl-2 family member, Bax, and alter-
ations in mitochondrial function would also be consistent
with the recent demonstration that Bax translocates from
the cytosol to the mitochondria during programmed cell
death (Hsu et al., 1997; Wolter et al., 1997). Analysis of
various Bax mutations indicated that cell death was only
observed when the Bax protein was capable of translocat-
ing to the mitochondria (Nechushtan et al., 1999).
The results of the present study suggest that Bax trans-
location to the mitochondria is subject to regulation by
p38 MAP kinase in response to nitric oxide. This finding is
consistent with the recent identification of domains in the
NH2 (Goping et al., 1998) and COOH termini (Nechush-
tan et al., 1999) that regulate Bax targeting to the mito-
chondria. Eliminating the NH2-terminal 19 amino acids of
Bax enhances membrane integration, suggesting that this
domain normally prevents mitochondrial insertion. This
domain is rich in glycine and hydroxylated amino acids
such as serine and threonine that are potential targets of
the p38 MAP kinase. Coincidentally, the Bax COOH ter-
minus contains a serine at position 184 that is critical for
regulating the subcellular distribution of Bax (Nechushtan
et al., 1999). Phosphorylation of either terminus may pre-
cipitate a conformational change, which facilitates mem-
brane insertion. However, evidence for Bax phosphoryla-
tion is lacking (Nechushtan et al., 1999), in contrast to the
related family members Bcl-2 and Bad (May et al., 1994;
Zha et al., 1996; Datta et al., 1997; Haldar et al., 1998;
Srivastava et al., 1999). Alternatively, it is conceivable that
while Bax is not directly phosphorylated, the phosphoryla-
tion of a Bax-binding protein may facilitate membrane tar-
geting and insertion (Desagher et al., 1999).
Bax translocation to the mitochondria has been shown
to reduce mitochondrial membrane potential, enhance cy-
tochrome c release from the mitochondria, and to activate
caspases (J.G. Xiang et al., 1996; Eskes et al., 1998; Jur-
gensmeier et al., 1998; Finucane et al., 1999; Desagher et al.,
1999). The significant reduction in caspase cleavage activ-
ity, which is observed in the present study after concurrent
treatment with SNP and the p38 MAP kinase inhibitor, is
consistent with our demonstration that Bax translocation
is regulated by p38 MAP kinase. Thus, we would propose
that SNP activates p38 MAP kinase, which promotes Bax
translocation to the mitochondria followed by cytochrome
c release and caspase activation. This is in agreement with
the temporal course of p38 activation that was first de-
tected 3–6 h after SNP treatment and before the first evi-
dence of Bax translocation (12 h) and caspase induction
(24 h). The residual caspase activity, which remained in
the presence of the p38 MAP kinase inhibitor, may reflect
a small degree of Bax translocation that was not detect-
able by confocal microscopy imaging of the GFP-Bax fu-
sion protein. Alternatively, caspase activation may have
resulted, in part, from a direct action of nitric oxide or its
derivative, peroxynitrite, on mitochondrial permeability
with subsequent release of cytochrome c (Packer and
Murphy, 1994; Vercesi et al., 1997; Brookes et al., 1998).
Irrespective of the mechanism of activation, caspase
activity did not play a major role in nitric oxide–induced
death of SH-SY5Y cells or primary cortical neurons. Al-
though the pan-caspase inhibitor, zVAD-fmk, blocked
DEVD cleavage activity more effectively than the p38 MAP
kinase inhibitor, it had no effect on the viability of primary
cortical neurons and only marginally delayed the death of
SH-SY5Y cells. These results suggest that SNP-induced
cell death occurs in a caspase-independent manner, al-
though cells were killed by apoptosis, which is defined as
an active process of cell death requiring the activation of
discrete biochemical pathways. SNP-induced cell death, as
studied in the present report, is considered to be apoptotic
based on the following criteria. First, cells exhibit nuclear
fragmentation and a significant reduction in volume (Fig.
6), morphological hallmarks of apoptosis. Images con-
tained in Fig. 6 clearly demonstrate that SNP promotes
Bax translocation in cells that are significantly shrunken
compared with nontreated control cells or cells concomi-
tantly treated with SNP and the p38 inhibitor, SB203580.
Necrotic cells typically exhibit swelling, which is not evi-
dent in these cultures. Second, SNP-treated cells exhibit
activation of two apoptotic signaling pathways, including
p38 MAP kinase activity (Fig. 1) and caspase cleavage ac-
tivity (Fig. 5). Third, cell death is suppressed by inhibiting
the p38 MAP kinase cascade or by the absence of the cell
death–promoting protein, Bax (Fig. 9). Thus, we would
conclude that Bax-mediated changes in mitochondrial
integrity could compromise neuronal viability indepen-
dently of caspase activation as recently suggested by our
laboratory (Johnson et al., 1998, 1999) and others (J.G.
Xiang et al., 1996; McCarthy et al., 1997; Miller et al., 1997;
Bergeron et al., 1998; Kim et al., 1998; Vercammen et al.,
1998).Ghatan et al. p38 MAP Kinase in Neuronal Cell Death 345
Bax Translocation Is Essential for Neuronal Cell Death
The present study suggests that Bax-dependent pathways
contribute to the death of postnatal neurons after injury.
Indeed, there is increasing evidence that Bax may play a
central role in both developmental and injury-induced cell
death in neurons. For example, targeted disruption of the
Bax gene significantly reduces the developmental death of
specific populations of peripheral and central nervous sys-
tem neurons (Deckwerth et al., 1996; Shindler et al., 1997;
White et al., 1998). In addition, the absence of Bax reduces
neuronal cell death in response to trophic factor depriva-
tion (Deckwerth et al., 1996; Easton et al., 1997), glu-
tamate exposure, and DNA damaging agents (Johnson et
al., 1998; Xiang et al., 1998). NGF deprivation recently has
been shown to initiate a caspase-independent subcellular
redistribution of Bax from the cytosol to the mitochondria
(Putcha et al., 1999), which is similar to our observations
with SNP. The addition of neuroprotective agents at the
time of NGF deprivation prevented Bax translocation.
The consistent finding that Bax translocation is proximal
to, and independent of, caspases suggests that the capacity
of Bax to promote neuronal cell death is likely depen-
dent on its pore forming properties and its ability to in-
crease mitochondrial membrane permeability (Eskes et
al., 1998).
The results of the present study indicate that increased
levels of nitric oxide, which have been implicated in the
pathogenesis of several acute and chronic neurological
disorders, may ultimately promote neuronal cell death
through mitochondrial dysfunction. Our results also dem-
onstrate that p38 MAP kinase plays an integral role in the
regulation of Bax translocation to the mitochondria. Tar-
geting the p38 MAP kinase and interrupting Bax translo-
cation may provide a means for maintaining neuronal via-
bility and metabolic competence following neurotoxic
insults.
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